A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line treatment of advanced biliary tract carcinoma

BACKGROUND: A paucity of effective treatment for biliary tract carcinoma (BTC) has necessitated the investigation into new therapies. As combinations of targeted therapy with immunotherapy are well-established in hepatocellular carcinoma, the GEMOX chemotherapy (gemcitabine and oxaliplatin) is the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Jie, Ma, Jie, Zeng, Zhiming, Yang, Lihua, Jiang, Yanfeng, Mo, Ning, Ma, Fuchao, Liu, Cuizhen, Li, Rong, Tang, Jing, Qin, Shanyu, Jiang, Haixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186497/
https://www.ncbi.nlm.nih.gov/pubmed/37201053
http://dx.doi.org/10.21037/jgo-23-218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186497/
https://www.ncbi.nlm.nih.gov/pubmed/37201053
http://dx.doi.org/10.21037/jgo-23-218

Ejemplares similares